Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
XAV-19 by Xenothera for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval
XAV-19 is under clinical development by Xenothera and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Pneumonia. According to...